Instant Report
FDF

Date: 16-Mar-2021

Maharashtra FDA Registers Consumption Of 450 Mt Of Oxygen Against 800 Mt During Lockdown Period

Despite surge in Covid-19 cases, the Maharashtra Food and Drug Administration (FDA) has registered a consumption of only 450 metric tonnes (MT) of medical oxygen as against 800 MT during the lockdown period.

According to official sources, adequate and regular supply of medical oxygen required for the treatment of Covid-19 has been started at Covid hospitals.

The combined production capacity of 30 manufacturers and 88 refillers/distributors in the state is 1287 MT per day. The state has a daily demand of 450 MT. Till date, stock at the producer level is 6227 MT of medical oxygen and 2489 MT at the hospital level.

The Maharashtra FDA Commissioner Abhimanyu Kale has assured availability of remdesivir injection, medical oxygen, face mask and hand sanitizer based on the review done recently by officials about availability of medicines required in the wake of surge in Covid-19 cases in Maharashtra.

Maharashtra FDA Minister Dr. Rajendra Shingane is regularly reviewing the availability of medicines for Covid-9 in the state and giving necessary directions to the administration. Maharashtra FDA Commissioner has appealed to the people to inform the administration on toll free number 1800222365 if there is any complaint regarding black marketing of medicines and other related products.

The Maharashtra FDA officials have assured that there are enough face masks and hand sanitizers required for the prevention of Covid-19 diseases in the state at present. N-95, 2 ply and 3 ply face masks are available to the public at reasonable prices.

Until February, 2021, there was available stock of 51,425 remdesivir injections, 20,15,381 favipiravir tablets 200/400 mg, stocks of medicines are available in Covid-19 hospital and drug distributors in the state. In addition, 1.97 lakh remdesivir injection stocks are available for distribution at Mylan Lab's Nagpur Depot. At present, the state has sufficient stock of medicine required for the treatment of Covid-19.

Date: 18-Mar-2021

Maharashtra FDA Registers Consumption Of 450 Mt Of Oxygen Against 800 Mt During Lockdown Period

Despite surge in Covid-19 cases, the Maharashtra Food and Drug Administration (FDA) has registered a consumption of only 450 metric tonnes (MT) of medical oxygen as against 800 MT during the lockdown period.

According to official sources, adequate and regular supply of medical oxygen required for the treatment of Covid-19 has been started at Covid hospitals.

The combined production capacity of 30 manufacturers and 88 refillers/distributors in the state is 1287 MT per day. The state has a daily demand of 450 MT. Till date, stock at the producer level is 6227 MT of medical oxygen and 2489 MT at the hospital level.

The Maharashtra FDA Commissioner Abhimanyu Kale has assured availability of remdesivir injection, medical oxygen, face mask and hand sanitizer based on the review done recently by officials about availability of medicines required in the wake of surge in Covid-19 cases in Maharashtra.

Maharashtra FDA Minister Dr. Rajendra Shingane is regularly reviewing the availability of medicines for Covid-9 in the state and giving necessary directions to the administration. Maharashtra FDA Commissioner has appealed to the people to inform the administration on toll free number 1800222365 if there is any complaint regarding black marketing of medicines and other related products.

The Maharashtra FDA officials have assured that there are enough face masks and hand sanitizers required for the prevention of Covid-19 diseases in the state at present. N-95, 2 ply and 3 ply face masks are available to the public at reasonable prices.

Until February, 2021, there was available stock of 51,425 remdesivir injections, 20,15,381 favipiravir tablets 200/400 mg, stocks of medicines are available in Covid-19 hospital and drug distributors in the state. In addition, 1.97 lakh remdesivir injection stocks are available for distribution at Mylan Lab's Nagpur Depot. At present, the state has sufficient stock of medicine required for the treatment of Covid-19